Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration

NCT00211536 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

107

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: Medtronic MiniMed Implantable Pump Human Recombinant Insulin
DEVICE: Medtronic MiniMed Implantable Pump System
DRUG: Aventis HOE21PH U400

Sponsor

Medtronic MiniMed, Inc.